Silexion TherapeuticsSLXN
13F holders, Q2 2026 (June 30)6holders
$2.49avg. 13F price*
At the end of Q2 2026, 6 institutions reported holding Silexion Therapeutics Corp. (SLXN) in their 13F filings. The largest holders were HRT Financial LP ($38K), UBS Group AG ($4K) and Montag A & Associates Inc. ($765).
- Company
- Silexion Therapeutics Corp.
- CUSIP
- G1281K148
- Latest filing quarter
- Q2 2026
Total Exit/New Position Q2 2026
| Institutions | Total Value | |
|---|---|---|
| New Positions | 6 | $42K |
| Exits | 0 | $0 |
Ownership 6 holders
| HRT Financial LP | 0.00% | New | 15,239 | $38K |
| UBS Group AG | 0.00% | New | 1,411 | $4K |
| Montag A & Associates Inc. | 0.00% | New | 300 | $765 |
| Pflug Koory, LLC | 0.00% | New | 33 | $84 |
| SBI Securities Co., Ltd. | 0.00% | New | 2 | $5 |
| Royal Bank of Canada | 0.00% | New | 76 | $0 |
"% of holder's portfolio" is SLXN's weight in each manager's 13F, not the share of Silexion Therapeutics Corp. the manager owns.